{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:10:09Z","timestamp":1790403009892,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:00:00Z","timestamp":1686009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:00:00Z","timestamp":1686009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The causal role of high-risk Human papillomavirus (HR-HPV) in the pathogenesis of anogenital cancers is well established. In contrast, information on HR-HPV distribution of continuous anatomic sites within the female genital tract is limited, and the impact of sample type on the clinical performance in HPV-based cervical cancer screening warrants investigation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 2,646 Chinese women were enrolled in the study from May 2006 to April 2007. We analyzed the infection features by infection status and pathological diagnoses of 489 women with complete HR-HPV type and viral load data on the cervix, upper vagina, lower vagina, and perineum samples. Additionally, we assessed the clinical performance for detecting high-grade cervical intraepithelial neoplasia of grade two or worse (\u2265\u2009CIN2) among these four types of samples.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      HR-HPV positivity rate was lower in the cervix (51.53%) and perineum (55.83%), higher in the upper (65.64%) and lower vagina (64.42%), and increased with the severity of cervical histological lesions (all P&lt;0.001). Single infection was more dominant than multiple infections at each anatomic site of the female genital tract. The proportion of single HR-HPV infection decreased successively from the cervix (67.05%) to the perineum (50.00%) (\n                      <jats:italic>P<\/jats:italic>\n                      <jats:sub>\n                        <jats:italic>trend<\/jats:italic>\n                      <\/jats:sub>\n                      =0.019) in cervical intraepithelial neoplasia grade 1 (CIN1) and was higher in samples of the cervix (85.11%) and perineum (72.34%) in \u2265\u2009CIN2. In addition, the highest viral load was observed in the cervix compared to the other three sites. The overall agreement of the cervical and perineum samples was 79.35% and increased continuously from normal (76.55%) to \u2265\u2009CIN2 (91.49%). As for the detection of \u2265\u2009CIN2, the sensitivity was 100.00%, 97.87%, 95.74%, and 91.49% for the cervix, upper vagina, lower vagina, and perineum samples, respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Single HR-HPV infection predominated throughout the female genital tract, but the viral load was lower compared to multiple HR-HPV infections. Despite the decreasing viral load from cervix to perineum, the clinical performance for detecting\u2009\u2265\u2009CIN2 of the perineum sample was comparable to that of the cervix.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12985-023-02073-4","type":"journal-article","created":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T15:13:02Z","timestamp":1686064382000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["The features of high-risk human papillomavirus infection in different female genital sites and impacts on HPV-based cervical cancer screening"],"prefix":"10.1186","volume":"20","author":[{"given":"Tingyuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeni","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youlin","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,6]]},"reference":[{"issue":"4","key":"2073_CR1","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/ijc.30716","volume":"141","author":"C de Martel","year":"2017","unstructured":"de Martel C, et al. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141(4):664\u201370. https:\/\/doi.org\/10.1002\/ijc.30716","journal-title":"Int J Cancer"},{"key":"2073_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.bpobgyn.2017.08.015","volume":"47","author":"S de Sanjos\u00e9","year":"2018","unstructured":"de Sanjos\u00e9 S, Brotons M, Pav\u00f3n MA. The natural history of human papillomavirus infection. Best Pract Res Clin Obstet Gynaecol. 2018;47:2\u201313. https:\/\/doi.org\/10.1016\/j.bpobgyn.2017.08.015","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"2 Suppl 1","key":"2073_CR3","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/j.ygyno.2007.07.067","volume":"107","author":"M Steben","year":"2007","unstructured":"Steben M, Duarte-Franco E. Human papillomavirus infection: epidemiology and pathophysiology. Gynecol Oncol. 2007;107(2 Suppl 1):S2\u20135. https:\/\/doi.org\/10.1016\/j.ygyno.2007.07.067","journal-title":"Gynecol Oncol"},{"key":"2073_CR4","doi-asserted-by":"publisher","unstructured":"Mirabello L, et al. HPV16 Sublineage Associations with Histology-Specific Cancer Risk using HPV whole-genome sequences in 3200 women. J Natl Cancer Inst. 2016;108(9). https:\/\/doi.org\/10.1093\/jnci\/djw100","DOI":"10.1093\/jnci\/djw100"},{"issue":"9590","key":"2073_CR5","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/s0140-6736(07)61416-0","volume":"370","author":"M Schiffman","year":"2007","unstructured":"Schiffman M, et al. Human papillomavirus and cervical cancer. Lancet. 2007;370(9590):890\u2013907. https:\/\/doi.org\/10.1016\/s0140-6736(07)61416-0","journal-title":"Lancet"},{"issue":"2","key":"2073_CR6","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1001\/jamaoncol.2020.6575","volume":"7","author":"J Zhang","year":"2021","unstructured":"Zhang J, et al. Effectiveness of high-risk human papillomavirus testing for Cervical Cancer Screening in China: a Multicenter, Open-label, Randomized Clinical Trial. JAMA Oncol. 2021;7(2):263\u201370. https:\/\/doi.org\/10.1001\/jamaoncol.2020.6575","journal-title":"JAMA Oncol"},{"key":"2073_CR7","doi-asserted-by":"publisher","unstructured":"Daponte A, et al. Urine HPV in the Context of Genital and Cervical Cancer Screening-An Update of current literature. Cancers (Basel). 2021;13(7). https:\/\/doi.org\/10.3390\/cancers13071640","DOI":"10.3390\/cancers13071640"},{"issue":"12","key":"2073_CR8","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.3760\/cma.j.cn112152-20190419-00252","volume":"43","author":"HF Xu","year":"2021","unstructured":"Xu HF, et al. [Acceptance evaluation of urine self-sampling, vaginal self-sampling and physician sampling in cervical cancer screening]. Zhonghua Zhong Liu Za Zhi. 2021;43(12):1282\u20136. https:\/\/doi.org\/10.3760\/cma.j.cn112152-20190419-00252","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"issue":"8","key":"2073_CR9","first-page":"597","volume":"63","author":"TR Madzima","year":"2017","unstructured":"Madzima TR, Vahabi M, Lofters A. Emerging role of HPV self-sampling in cervical cancer screening for hard-to-reach women: focused literature review. Can Fam Physician. 2017;63(8):597\u2013601.","journal-title":"Can Fam Physician"},{"issue":"3","key":"2073_CR10","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/jnci\/djr532","volume":"104","author":"FH Zhao","year":"2012","unstructured":"Zhao FH, et al. Pooled analysis of a self-sampling HPV DNA test as a cervical cancer primary screening method. J Natl Cancer Inst. 2012;104(3):178\u201388. https:\/\/doi.org\/10.1093\/jnci\/djr532","journal-title":"J Natl Cancer Inst"},{"key":"2073_CR11","doi-asserted-by":"publisher","first-page":"g5542","DOI":"10.1136\/bmj.g5542","volume":"349","author":"HC Kitchener","year":"2014","unstructured":"Kitchener HC, Owens GL. Urine testing for HPV. BMJ. 2014;349:g5542. https:\/\/doi.org\/10.1136\/bmj.g5542","journal-title":"BMJ"},{"issue":"8","key":"2073_CR12","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1111\/j.1743-6109.2008.00875.x","volume":"5","author":"HE O\u2019Connell","year":"2008","unstructured":"O\u2019Connell HE, et al. The anatomy of the distal vagina: towards unity. J Sex Med. 2008;5(8):1883\u201391. https:\/\/doi.org\/10.1111\/j.1743-6109.2008.00875.x","journal-title":"J Sex Med"},{"issue":"2","key":"2073_CR13","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.canep.2014.01.004","volume":"38","author":"SK Zhang","year":"2014","unstructured":"Zhang SK, et al. Comparison of HPV genotypes and viral load between different sites of genital tract: the significance for cervical cancer screening. Cancer Epidemiol. 2014;38(2):168\u201373. https:\/\/doi.org\/10.1016\/j.canep.2014.01.004","journal-title":"Cancer Epidemiol"},{"issue":"5","key":"2073_CR14","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1002\/ijc.25144","volume":"127","author":"JL Belinson","year":"2010","unstructured":"Belinson JL, et al. Prevalence of type-specific human papillomavirus in endocervical, upper and lower vaginal, perineal and vaginal self-collected specimens: implications for vaginal self-collection. Int J Cancer. 2010;127(5):1151\u20137. https:\/\/doi.org\/10.1002\/ijc.25144","journal-title":"Int J Cancer"},{"issue":"7","key":"2073_CR15","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1128\/jcm.02438-06","volume":"45","author":"MP Stevens","year":"2007","unstructured":"Stevens MP, et al. Comparison of the Digene Hybrid capture 2 assay and Roche AMPLICOR and LINEAR ARRAY human papillomavirus (HPV) tests in detecting high-risk HPV genotypes in specimens from women with previous abnormal pap smear results. J Clin Microbiol. 2007;45(7):2130\u20137. https:\/\/doi.org\/10.1128\/jcm.02438-06","journal-title":"J Clin Microbiol"},{"issue":"6","key":"2073_CR16","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1002\/ijc.29877","volume":"138","author":"M Valdez","year":"2016","unstructured":"Valdez M, et al. Effectiveness of novel, lower cost molecular human papillomavirus-based tests for cervical cancer screening in rural china. Int J Cancer. 2016;138(6):1453\u201361. https:\/\/doi.org\/10.1002\/ijc.29877","journal-title":"Int J Cancer"},{"issue":"6","key":"2073_CR17","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1002\/ijc.31128","volume":"142","author":"F Wei","year":"2018","unstructured":"Wei F, et al. The prevalence and concordance of human papillomavirus infection in different anogenital sites among men and women in Liuzhou, China: a population-based study. Int J Cancer. 2018;142(6):1244\u201351. https:\/\/doi.org\/10.1002\/ijc.31128","journal-title":"Int J Cancer"},{"issue":"1","key":"2073_CR18","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12889-019-6487-9","volume":"19","author":"Y Ge","year":"2019","unstructured":"Ge Y, et al. Prevalence of human papillomavirus infection of 65,613 women in East China. BMC Public Health. 2019;19(1):178. https:\/\/doi.org\/10.1186\/s12889-019-6487-9","journal-title":"BMC Public Health"},{"issue":"3","key":"2073_CR19","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/jmv.25331","volume":"91","author":"M Li","year":"2019","unstructured":"Li M, et al. Prevalence characteristics of single and multiple HPV infections in women with cervical cancer and precancerous lesions in Beijing, China. J Med Virol. 2019;91(3):473\u201381. https:\/\/doi.org\/10.1002\/jmv.25331","journal-title":"J Med Virol"},{"issue":"7","key":"2073_CR20","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1093\/infdis\/jiq139","volume":"203","author":"AK Chaturvedi","year":"2011","unstructured":"Chaturvedi AK, et al. Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease. J Infect Dis. 2011;203(7):910\u201320. https:\/\/doi.org\/10.1093\/infdis\/jiq139","journal-title":"J Infect Dis"},{"issue":"5","key":"2073_CR21","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1128\/jcm.00087-13","volume":"51","author":"M Schmitt","year":"2013","unstructured":"Schmitt M, et al. Multiple human papillomavirus infections with high viral loads are associated with cervical lesions but do not differentiate grades of cervical abnormalities. J Clin Microbiol. 2013;51(5):1458\u201364. https:\/\/doi.org\/10.1128\/jcm.00087-13","journal-title":"J Clin Microbiol"},{"issue":"1","key":"2073_CR22","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12879-017-2223-1","volume":"17","author":"L Zhang","year":"2017","unstructured":"Zhang L, et al. Human papillomavirus infections among women with cervical lesions and cervical cancer in Eastern China: genotype-specific prevalence and attribution. BMC Infect Dis. 2017;17(1):107. https:\/\/doi.org\/10.1186\/s12879-017-2223-1","journal-title":"BMC Infect Dis"},{"issue":"6","key":"2073_CR23","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1007\/s00404-020-05787-w","volume":"302","author":"J Zhang","year":"2020","unstructured":"Zhang J, Cheng K, Wang Z. Prevalence and distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia in China: a meta-analysis. Arch Gynecol Obstet. 2020;302(6):1329\u201337. https:\/\/doi.org\/10.1007\/s00404-020-05787-w","journal-title":"Arch Gynecol Obstet"},{"key":"2073_CR24","doi-asserted-by":"publisher","unstructured":"Oyervides-Mu\u00f1oz MA, et al. Multiple HPV infections and viral load Association in Persistent Cervical Lesions in Mexican Women. Viruses. 2020;12(4). https:\/\/doi.org\/10.3390\/v12040380","DOI":"10.3390\/v12040380"},{"issue":"9","key":"2073_CR25","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.cmi.2015.04.015","volume":"21","author":"M Arbyn","year":"2015","unstructured":"Arbyn M, et al. Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening? Clin Microbiol Infect. 2015;21(9):817\u201326. https:\/\/doi.org\/10.1016\/j.cmi.2015.04.015","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"2073_CR26","first-page":"477","volume":"12","author":"PE Gravitt","year":"2003","unstructured":"Gravitt PE, et al. A comparison between real-time polymerase chain reaction and hybrid capture 2 for human papillomavirus DNA quantitation. Cancer Epidemiol Biomarkers Prev. 2003;12(6):477\u201384.","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-023-02073-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-023-02073-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-023-02073-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T15:16:41Z","timestamp":1686064601000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-023-02073-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,6]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2073"],"URL":"https:\/\/doi.org\/10.1186\/s12985-023-02073-4","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,6]]},"assertion":[{"value":"21 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the institutional review board (IRB) of the Cleveland Clinic and the Cancer Institute\/Hospital of the Chinese Academy of Medical Sciences (CICAMS). All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"116"}}